Document is current
Any future updates will be listed below
-
Authors
Verma, Vivek https://orcid.org/0000-0001-8129-4140
Jafarzadeh, Nazli
Boi, Shannon https://orcid.org/0000-0001-9479-5665
Kundu, Subhadip
Jiang, Zhinuo https://orcid.org/0000-0003-2059-2077
Fan, Yiping
Lopez, Jose
Nandre, Rahul
Zeng, Peng
Alolaqi, Fatmah
Ahmad, Shamim
Gaur, Pankaj
Barry, Simon T.
Valge-Archer, Viia E.
Smith, Paul D.
Banchereau, Jacques https://orcid.org/0000-0003-3535-7221
Mkrtichyan, Mikayel
Youngblood, Benjamin https://orcid.org/0000-0002-1261-9957
Rodriguez, Paulo C. https://orcid.org/0000-0001-7480-6566
Gupta, Seema https://orcid.org/0000-0003-0106-595X
Khleif, Samir N. https://orcid.org/0000-0003-2707-5224
- License Information
-
More Information
Article History
Received: 11 March 2020
Accepted: 8 October 2020
First Online: 23 November 2020
Competing interests
: S.N.K. and V.V. are inventors on patent applications related to work on the induction of T<sub>SCM</sub> by MEK1/2 inhibition in T cells and methods for use of these T<sub>SCM</sub> in various therapeutic applications. S.N.K. reports honoraria from Syndax, IOBiotech, Bioline Therapeutics, Northwest Biotherapeutics, Advaxis, EMD Serono, GSK, UbiVac, McKinsey, AstraZeneca and Lycera. S.N.K. reports stocks or ownership interest in Advaxis, GeorgiaImmune, IOBiotech and Northwest Therapeutics. S.N.K. is a consultant for Syndax, IOBiotech, Bioline, Kahr, PDS Biotechnology, AstraZeneca, CytomX, NewLink Genetics, AratingaBio, CanImGuide and Lycera. S.N.K. is a board member for Advaxis. S.N.K. has research contracts with Syndax, IOBiotech, Bioline Therapeutics, AstraZeneca, MedImmune and Lycera. J.B. is on the Board of Directors of Neovacs and Stamford Pharmaceutical and is a member of the CUE Biopharma and GeorgiaImmune SABs. J.B. reports stock or ownership interest in Neovacs, Stamford Pharmaceuticals and Cue Biopharma. J.B. has a research contract with Sanofi.
